According to The New England Journal of Medicine, investigators at Uppsala University Hospital implanted a product called ...

So, even via the more modest predictions, people will be able to double their longevity. When you reach 100 years old, you ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

Scientists from the University of California, Davis have developed a new type of wheat capable of producing part of its ...

Georgia students broke into the world spotlight after showcasing early Lyme detection advances that could save patients years of suffering.

Title: CRISPR/Cas-mediated APOC3 Knockout as a One-time Treatment for Severe Hypertriglyceridemia Presenters: Alan Brooks, PhD, Senior Vice President of Research at Metagenomi Date/time: Monday, ...

Meta: \{"__typename":"TimeAuthorPageMetadata","title":"Markham Heid \| TIME","description":"Read the latest stories by ...

Absolutely! Please provide the article for which you'd like an SEO-friendly meta description, and I'll generate one based on your input.

As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...

This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...